Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- WEAVER LABS LLC
- Proposal award date
- 2021-04-01
- Contract end date
- 2022-09-30
- UEI
- ENWMQ5VRY2S5
- Solicitation number
- PA19-272
- Topic code
- R
Research abstract
AbstractPolyfluoro- and perfluoroalkyl substances (PFAS) are a group of highly fluorinated alkanes. Members of this
family are known to be persistent and bioaccumulative. PFAS are associated with unfavorable health outcomes
in human and animal models. Several public health agencies as well as scientists have published articles that
indicate the presence of PFAS in human blood, serum, milk, cord blood, and tissues. Currently, detection of
about a dozen of these chemicals out of more than a thousand of this class is performed using LCMS/MS.
However, prior to analysis many purification steps are required to eliminate interfering species. Furthermore, the
necessity of internal standards for the detection of PFAS, and the lack of pertinent internal standards dramatically
reduces the scope of PFAS-detection. Currently, PFAS testing is a lengthy and costly undertaking that
represents a major scientific bottleneck. Thus, there is an urgent need for a real-time detection technology that
can sense a broad range of PFAS without pretreatment of sample, or expensive instrumentation. Implementation
of such a product will allow better understanding of the fate of PFAS within the environment and their impact on
human health.This proposal’s objective is to develop the pre-treatment free detection of PFAS in environmental matrices by
coupling the key fluorous phase property with a highly sensitive fluorescence technology. In phase 1, we will
apply the specific fluorous-fluorous interaction strategy to provide the adequate selectivity to preclude any
associated purification steps. Fluorous tethered fluorescent dyes will be covalently immobilized on a glass
surface. Initially, prior to exposure to PFAS, these fluorescent dyes will exist as excimers resulting from their
close proximity to each other, the fluorescent probe turns the fluorescence on. Upon exposure to PFAS analytes,
the analytes will be sequestered to the fluorous region of the probe due to specific fluorous-fluorous affinity. This
will cause a physical disruption of the excimers, resulting in the fluorescence turn off of the excimer and a
simultaneous turn on of the monomer emission. To achieve the proposed goal, in phase I the following specific
aims will be pursued: specific aim1: 1) attachment of the fluorescent dye to the fluorous molecule, 2)
immobilization of fluorous-dye array on glass surface, and 3) evaluation of fluorescence on-off of fluorous-dye
glass surface with PFAS-samples. Ultimately the approach developed here will lay the groundwork for the
development of a product that is expected to enable a broad range of researchers to study many types of effects
on human health caused by PFAS.Project Narrative
Rapid detection and quantification of PFAS is an immediate need for better understanding their properties such
as their partition in different environmental matrices, health risks, exposure routes, fate and transportation, etc.
In order to drive advancement of such study a novel approach will be applied for generation of chip-based PFAS
sensors that can rapidly detect and quantify a broad range of PFAS in environmental matrices such as ground
water, surface water, soil, etc. This technique is eventually expected to lead to a portable device that can enable
the generation of bountiful information that will facilitate regulatory decision making, monitoring of PFAS sources,
and ultimately reducing future exposures that benefit society.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
5 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $621,479. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, Department of Agriculture
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards